Ensituximab (Anti-MUC5AC)

Synonyms: NEO-102

Ensituximab (Anti-MUC5AC) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC with specificity for colorectal and pancreatic cancer. MW: 145.5 kD.

Ensituximab (Anti-MUC5AC)

Purity & Quality Control

Biological Activity

Description Ensituximab (Anti-MUC5AC) is a chimeric monoclonal IgG1 antibody targeting a variant of MUC5AC with specificity for colorectal and pancreatic cancer. MW: 145.5 kD.

Product Details

CAS No. 1092658-06-4
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ensituximab (Anti-MUC5AC) | Ensituximab (Anti-MUC5AC) supplier | purchase Ensituximab (Anti-MUC5AC) | Ensituximab (Anti-MUC5AC) cost | Ensituximab (Anti-MUC5AC) manufacturer | order Ensituximab (Anti-MUC5AC) | Ensituximab (Anti-MUC5AC) distributor